keyword
https://read.qxmd.com/read/38635243/aspergillus-fumigatus-hypoxia-adaptation-is-critical-for-the-establishment-of-fungal-keratitis
#21
JOURNAL ARTICLE
Jorge D Lightfoot, Emily M Adams, Manali M Kamath, Becca L Wells, Kevin K Fuller
PURPOSE: The poor visual outcomes associated with fungal keratitis (FK) underscore a need to identify fungal pathways that can serve as novel antifungal targets. In this report, we investigated whether hypoxia develops in the FK cornea and, by extension, if fungal hypoxia adaptation is essential for virulence in this setting. METHODS: C57BL/6J mice were inoculated with Aspergillus fumigatus and Fusarium solani var. petroliphilum via topical overlay or intrastromal injection...
April 1, 2024: Investigative Ophthalmology & Visual Science
https://read.qxmd.com/read/38633650/eepd1-is-identified-as-a-predictor-of-prognosis-and-immune-microenvironment-through-pan-cancer-analysis-and-related-to-progression-of-colorectal-cancer
#22
JOURNAL ARTICLE
Yang Guo, Shujin Li, Zhan Shi, Bingchen Chen, Ziang Wan, Peng Yu, Boan Zheng, Wenjing Gong, Rui Chai, Shiliang Tu, Hang Yuan
BACKGROUND: EEPD1 is vital in homologous recombination, while its role in cancer remains unclear. METHODS: We performed multiple pan-cancer analyses of EEPD1 with bioinformatics methods, such as gene expression, gene alterations, Prognosis and enrichment analysis, tumor microenvironment, immune cell infiltration, TMB, MSI, immunotherapy, co-expression of genes, and drug resistance. Finally, RT-qPCR, EdU, and transwell assays helped investigate the impact of EEPD1 on CRC cells...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38633263/boosting-the-immunogenicity-of-the-coronavac-sars-cov-2-inactivated-vaccine-with-huoxiang-suling-shuanghua-decoction-a-randomized-double-blind-placebo-controlled-study
#23
JOURNAL ARTICLE
Ruying Tang, Linyuan Wang, Jianjun Zhang, Wenting Fei, Rui Zhang, Jinlian Liu, Meiyu Lv, Mengyao Wang, Ruilin Lv, Haipeng Nan, Ran Tao, Yawen Chen, Yan Chen, Yanxin Jiang, Hui Zhang
INTRODUCTION: In light of the public health burden of the COVID-19 pandemic, boosting the safety and immunogenicity of COVID-19 vaccines is of great concern. Numerous Traditional Chinese medicine (TCM) preparations have shown to beneficially modulate immunity. Based on pilot experiments in mice that showed that supplementation with Huoxiang Suling Shuanghua Decoction (HSSD) significantly enhances serum anti-RBD IgG titers after inoculation with recombinant SARS-CoV-2 S-RBD protein, we conducted this randomized, double-blind, placebo-controlled clinical trial aimed to evaluate the potential immunogenicity boosting effect of oral HSSD after a third homologous immunization with Sinovac's CoronaVac SARS-CoV-2 (CVS) inactivated vaccine...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38632539/prominent-transcriptomic-changes-in-mycobacterium-intracellulare-under-acidic-and-oxidative-stress
#24
JOURNAL ARTICLE
Hyun-Eui Park, Kyu-Min Kim, Jeong-Ih Shin, Jeong-Gyu Choi, Won-Jun An, Minh Phuong Trinh, Kyeong-Min Kang, Jung-Wan Yoo, Jung-Hyun Byun, Myung Hwan Jung, Kon-Ho Lee, Hyung-Lyun Kang, Seung Cheol Baik, Woo-Kon Lee, Min-Kyoung Shin
BACKGROUND: Mycobacterium avium complex (MAC), including Mycobacterium intracellulare is a member of slow-growing mycobacteria and contributes to a substantial proportion of nontuberculous mycobacterial lung disease in humans affecting immunocompromised and elderly populations. Adaptation of pathogens in hostile environments is crucial in establishing infection and persistence within the host. However, the sophisticated cellular and molecular mechanisms of stress response in M. intracellulare still need to be fully explored...
April 17, 2024: BMC Genomics
https://read.qxmd.com/read/38630886/lp-184-a-novel-acylfulvene-molecule-exhibits-anti-cancer-activity-against-diverse-solid-tumors-with-homologous-recombination-deficiency
#25
JOURNAL ARTICLE
Aditya Kulkarni, Jianli Zhou, Neha Biyani, Umesh Kathad, Partha P Banerjee, Shiv Srivastava, Zsombor Prucsi, Kamil Solarczyk, Kishor Bhatia, Reginald B Ewesuedo, Panna Sharma
Homologous recombination (HR) related gene alterations are present in a significant subset of prostate, breast, ovarian, pancreatic, lung and colon cancers rendering these tumors as potential responders to specific DNA damaging agents. A small molecule acylfulvene prodrug, LP-184, metabolizes to an active compound by the oxidoreductase activity of enzyme Prostaglandin Reductase 1 (PTGR1), which is frequently elevated in multiple solid tumor types. Prior work demonstrated that cancer cell lines deficient in a spectrum of (DNA damage repair) DDR pathway genes show increased susceptibility to LP-184...
April 17, 2024: Cancer Res Commun
https://read.qxmd.com/read/38630271/when-dna-damage-responses-meet-innate-and-adaptive-immunity
#26
REVIEW
Jie Tong, Jiangwei Song, Wuchao Zhang, Jingbo Zhai, Qingli Guan, Huiqing Wang, Gentao Liu, Chunfu Zheng
When cells proliferate, stress on DNA replication or exposure to endogenous or external insults frequently results in DNA damage. DNA-Damage Response (DDR) networks are complex signaling pathways used by multicellular organisms to prevent DNA damage. Depending on the type of broken DNA, the various pathways, Base-Excision Repair (BER), Nucleotide Excision Repair (NER), Mismatch Repair (MMR), Homologous Recombination (HR), Non-Homologous End-Joining (NHEJ), Interstrand Crosslink (ICL) repair, and other direct repair pathways, can be activated separately or in combination to repair DNA damage...
April 17, 2024: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/38629456/phase-ii-trial-of-niraparib-for-brca-mutated-biliary-tract-pancreatic-and-other-gastrointestinal-cancers-nir-b
#27
REVIEW
Yasuyuki Kawamoto, Chigusa Morizane, Yoshito Komatsu, Shunsuke Kondo, Makoto Ueno, Satoshi Kobayashi, Masayuki Furukawa, Lingaku Lee, Taroh Satoh, Daisuke Sakai, Masafumi Ikeda, Hiroshi Imaoka, Arisa Miura, Yutaka Hatanaka, Isao Yokota, Yoshiaki Nakamura, Takayuki Yoshino
Due to the widespread use of cancer genetic testing in gastrointestinal cancer, the BRCA1/2 genetic mutation has been identified in biliary tract cancer as well as pancreatic cancer. Niraparib is a poly(ADP-ribose) polymerase (PARP) inhibitor, and PARP inhibitors exert their cytotoxicity against cancer cells in the context of homologous recombination deficiency, such as BRCA mutations, via the mechanism of synthetic lethality. The aim of this phase II NIR-B trial is to evaluate the efficacy and safety of niraparib for patients with unresectable advanced or recurrent biliary tract cancer, pancreatic cancer or other gastrointestinal cancers with germline or somatic BRCA1/2 mutations revealed by genetic testing...
April 17, 2024: Future Oncology
https://read.qxmd.com/read/38628049/management-of-advanced-prostate-cancer-in-the-asia-pacific-region-summary-of-the-asia-pacific-advanced-prostate-cancer-consensus-conference-2023
#28
JOURNAL ARTICLE
Edmund Chiong, Declan G Murphy, Nicholas Buchan, Kenneth Chen, Sarah S Chen, Melvin L K Chua, Agus Rizal Hamid, Ravindran Kanesvaran, Makarand Khochikar, Jason Letran, Bannakij Lojanapiwat, Indranil Mallik, Chee Fai Ng, Teng Aik Ong, Darren M C Poon, Yeong-Shiau Pu, Marniza Saad, Kathryn Schubach, Kiyoshi Takahara, Jeremy Tey, Sue-Ping Thang, Poh Choo Toh, Levent Türkeri, Nguyễn Tuấn Vinh, Scott Williams, Dingwei Ye, Ian D Davis
AIM: The aim of the third Asia-Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2023) was to discuss the application in the Asia-Pacific (APAC) region of consensus statements from the 4th Advanced Prostate Cancer Consensus Conference (APCCC 2022). METHODS: The one-day meeting in July 2023 brought together 27 experts from 14 APAC countries. The meeting covered five topics: (1) Intermediate- and high-risk and locally advanced prostate cancer; (2) Management of newly diagnosed metastatic hormone-sensitive prostate cancer; (3) Management of non-metastatic castration-resistant prostate cancer; (4) Homologous recombination repair mutation testing; (5) Management of metastatic castration-resistant prostate cancer...
April 16, 2024: Asia-Pacific Journal of Clinical Oncology
https://read.qxmd.com/read/38627785/gata3-functions-downstream-of-brca1-to-promote-dna-damage-repair-and-suppress-dedifferentiation-in-breast-cancer
#29
JOURNAL ARTICLE
Xuejie Wang, Feng Bai, Xiong Liu, Bin Peng, Xingzhi Xu, Hongquan Zhang, Li Fu, Wei-Guo Zhu, Bin Wang, Xin-Hai Pei
BACKGROUND: Inadequate DNA damage repair promotes aberrant differentiation of mammary epithelial cells. Mammary luminal cell fate is mainly determined by a few transcription factors including GATA3. We previously reported that GATA3 functions downstream of BRCA1 to suppress aberrant differentiation in breast cancer. How GATA3 impacts DNA damage repair preventing aberrant cell differentiation in breast cancer remains elusive. We previously demonstrated that loss of p18, a cell cycle inhibitor, in mice induces luminal-type mammary tumors, whereas depletion of either Brca1 or Gata3 in p18 null mice leads to basal-like breast cancers (BLBCs) with activation of epithelial-mesenchymal transition (EMT)...
April 16, 2024: BMC Biology
https://read.qxmd.com/read/38625917/activated-nad-biosynthesis-pathway-induces-olaparib-resistance-in-brca1-knockout-pancreatic-cancer-cells
#30
JOURNAL ARTICLE
Yuka Sasaki, Takuma Inouchi, Ryusuke Nakatsuka, Amane Inoue, Mitsuko Masutani, Tadashige Nozaki
PARP inhibitors have been developed as anti-cancer agents based on synthetic lethality in homologous recombination deficient cancer cells. However, resistance to PARP inhibitors such as olaparib remains a problem in clinical use, and the mechanisms of resistance are not fully understood. To investigate mechanisms of PARP inhibitor resistance, we established a BRCA1 knockout clone derived from the pancreatic cancer MIA PaCa-2 cells, which we termed C1 cells, and subsequently isolated an olaparib-resistant C1/OLA cells...
2024: PloS One
https://read.qxmd.com/read/38624219/identification-and-recombinant-expression-of-a-cutinase-from-papiliotrema-laurentii-that-hydrolyzes-natural-and-synthetic-polyesters
#31
JOURNAL ARTICLE
Victor A Roman, Bryan R Crable, Dominique N Wagner, Andrii Gryganskyi, Stephen Zelik, Logan Cummings, Chia S Hung, Lloyd J Nadeau, Lucas Schratz, Sajeet Haridas, Jasmyn Pangilinan, Anna Lipzen, Hyunsoo Na, Mi Yan, Vivian Ng, Igor V Grigoriev, Daniel Barlow, Justin Biffinger, Nancy Kelley-Loughnane, Wendy J Crookes-Goodson, Blake Stamps, Vanessa A Varaljay
Given the multitude of extracellular enzymes at their disposal, many of which are designed to degrade nature's polymers (lignin, cutin, cellulose, etc.), fungi are adept at targeting synthetic polyesters with similar chemical composition. Microbial-influenced deterioration of xenobiotic polymeric surfaces is an area of interest for material scientists as these are important for the conservation of the underlying structural materials. Here, we describe the isolation and characterization of the Papiliotrema laurentii 5307AH ( P...
April 16, 2024: Applied and Environmental Microbiology
https://read.qxmd.com/read/38623425/characterization-of-a-novel-ribose-5-phosphate-isomerase-b-from-curtobacterium-flaccumfaciens-zxl1-for-d-allose-production
#32
JOURNAL ARTICLE
Qian Zheng, Si Long, Zhi Chen, Jiaolong Fu, Xin Ju, Liangzhi Li
Enzymatic preparation of rare sugars as an alternative to traditional sweeteners is an effective strategy to achieve a low-calorie healthy diet. Ribose-5-phosphate isomerase B (RpiB) is a key enzyme in the non-oxidative branch of the catalytic pentose phosphate pathway. Here, we investigated the potential of Curtobacterium flaccumfaciens ZXL1 ( C. flaccumfaciens ZXL1) derived RpiB (CfRpiB) in D-allose preparation. The optimal reaction conditions for recombinant CfRpiB were found experimentally to be pH 7.0, 55 °C, and no metal ions...
June 2024: Food Science and Biotechnology
https://read.qxmd.com/read/38622517/investigating-pigeon-circovirus-infection-in%C3%A2-a-pigeon-farm-molecular-detection-%C3%A2-phylogenetic-analysis-and-complete-genome-analysis
#33
JOURNAL ARTICLE
Xiaobo Li, Shujing Wang, Wei Li, Shasha Wang, Xiao Qin, Ji Wang, Rui Fu
BACKGROUND: Pigeon circovirus infections in pigeons (Columba livia domestica) have been reported worldwide. Pigeons should be PiCV-free when utilized as qualified experimental animals. However, pigeons can be freely purchased as experimental animals without any clear guidelines to follow. Herein, we investigated the status quo of PiCV infections on a pigeon farm in Beijing, China, which provides pigeons for experimental use. RESULTS: PiCV infection was verified in at least three types of tissues in all forty pigeons tested...
April 16, 2024: BMC Genomics
https://read.qxmd.com/read/38621543/asp-trna-asn-glu-trna-gln-amidotransferase-a-subunit-like-amidase-mediates-the-degradation-of-insecticide-flonicamid-by-variovorax-boronicumulans-cgmcc-4969
#34
JOURNAL ARTICLE
Xue-Xiu Yu, Ke-Xin Chen, Pan-Pan Yuan, Yu-He Wang, Hua-Xiao Li, Yun-Xiu Zhao, Yi-Jun Dai
The main metabolic product of the pyridinecarboxamide insecticide flonicamid, N-(4-trifluoromethylnicotinyl)glycinamide (TFNG-AM), has been shown to have very high mobility in soil, leading to its accumulation in the environment. Catabolic pathways of flonicamid have been widely reported, but few studies have focused on the metabolism of TFNG-AM. Here, the rapid transformation of TFNG-AM and production of the corresponding acid product N-(4-trifluoromethylnicotinoyl) glycine (TFNG) by the plant growth-promoting bacterium Variovorax boronicumulans CGMCC 4969 were investigated...
April 13, 2024: Science of the Total Environment
https://read.qxmd.com/read/38619241/using-the-pan-genomic-framework-for-the-discovery-of-genomic-islands-in-the-haloarchaeon-halorubrum-ezzemoulense
#35
JOURNAL ARTICLE
Yutian Feng, Danielle Arsenault, Artemis S Louyakis, Neta Altman-Price, Uri Gophna, R Thane Papke, Johann Peter Gogarten
In this study, we use pan-genomics to characterize the genomic variability of the widely dispersed halophilic archaeal species Halorubrum ezzemoulense (Hez ). We include a multi-regional sampling of newly sequenced, high-quality draft genomes. The pan-genome graph of the species reveals 50 genomic islands that represent rare accessory genetic capabilities available to members. Most notably, we observe rearrangements that have led to the insertion/recombination/replacement of mutually exclusive genomic islands in equivalent genome positions ("homeocassettes")...
April 15, 2024: MBio
https://read.qxmd.com/read/38616491/boosting-genome-editing-in-plants-with-single-transcript-unit-surrogate-reporter-systems
#36
JOURNAL ARTICLE
Xu Tang, Qiurong Ren, Xiaodan Yan, Rui Zhang, Li Liu, Qinqin Han, Xuelian Zheng, Yiping Qi, Hongyuan Song, Yong Zhang
CRISPR-Cas-based genome editing holds immense promise for advancing plant genomics and crop enhancement. However, the challenge of low editing activity complicates the identification of edited events. In this study, we introduce multiple Single Transcript Unit Surrogate Reporter (STU-SR) systems to enhance the selection of genome-edited plants. These systems utilize the same sgRNAs designed for endogenous genes to edit reporter genes, establishing a direct link between reporter gene editing activity and that of endogenous genes...
April 13, 2024: Plant communications
https://read.qxmd.com/read/38615317/protocol-for-genomic-recombineering-in-yersinia-ruckeri-using-crispr-cas12a-coupled-with-the-%C3%AE-red-system
#37
JOURNAL ARTICLE
Rooshanie N Ejaz, Nicholas M I Taylor, Eva M Steiner-Rebrova
Genomic manipulation of Yersinia ruckeri, a pathogen of salmonid fish species, is essential for understanding bacterial physiology and virulence. Here, we present a protocol for genomic recombineering in Y. ruckeri, a species reluctant to standard genomic engineering, using CRISPR Cas12a coupled with the λ Red system. We describe steps for identifying protospacer guides, preparing repair template plasmids, and electroporating Yersinia cells with Cpf1 and protospacer plasmids with homologous arms...
April 12, 2024: STAR protocols
https://read.qxmd.com/read/38613872/first-line-combination-treatment-with-parp-and-androgen-receptor-signaling-inhibitors-in-hrr-deficient-mcrpc-applying-clinical-study-findings-to-clinical-practice-in-the-united-states
#38
REVIEW
Rana R McKay, Alicia K Morgans, Neal D Shore, Curtis Dunshee, Geeta Devgan, Neeraj Agarwal
INTRODUCTION: Metastatic castration-resistant prostate cancer (mCRPC) remains incurable and develops from biochemically recurrent PC treated with androgen deprivation therapy (ADT) following definitive therapy for localized PC, or from metastatic castration-sensitive PC (mCSPC). In the mCSPC setting, treatment intensification of ADT plus androgen receptor (AR)-signaling inhibitors (ARSIs), with or without chemotherapy, improves outcomes vs ADT alone. Despite multiple phase 3 trials demonstrating a survival benefit of treatment intensification in PC, there remains high use of ADT monotherapy in real-world clinical practice...
March 29, 2024: Cancer Treatment Reviews
https://read.qxmd.com/read/38612903/characterization-of-the-first-secreted-sorting-nexin-identified-in-the-leishmania-protists
#39
JOURNAL ARTICLE
Olympia Tziouvara, Marina Petsana, Drosos Kourounis, Amalia Papadaki, Efthimia Basdra, Georgia G Braliou, Haralabia Boleti
Proteins of the sorting nexin (SNX) family present a modular structural architecture with a phox homology (PX) phosphoinositide (PI)-binding domain and additional PX structural domains, conferring to them a wide variety of vital eukaryotic cell's functions, from signal transduction to membrane deformation and cargo binding. Although SNXs are well studied in human and yeasts, they are poorly investigated in protists. Herein, is presented the characterization of the first SNX identified in Leishmania protozoan parasites encoded by the Ld BPK_352470 gene...
April 7, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612902/agnostic-administration-of-targeted-anticancer-drugs-looking-for-a-balance-between-hype-and-caution
#40
REVIEW
Svetlana N Aleksakhina, Alexander O Ivantsov, Evgeny N Imyanitov
Many tumors have well-defined vulnerabilities, thus potentially allowing highly specific and effective treatment. There is a spectrum of actionable genetic alterations which are shared across various tumor types and, therefore, can be targeted by a given drug irrespective of tumor histology. Several agnostic drug-target matches have already been approved for clinical use, e.g., immune therapy for tumors with microsatellite instability (MSI) and/or high tumor mutation burden (TMB), NTRK1-3 and RET inhibitors for cancers carrying rearrangements in these kinases, and dabrafenib plus trametinib for BRAF V600E mutated malignancies...
April 7, 2024: International Journal of Molecular Sciences
keyword
keyword
7536
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.